159 related articles for article (PubMed ID: 24763737)
21. C-C Motif Chemokine Receptor 9 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy and Dysfunction.
Xu Z; Mei F; Liu H; Sun C; Zheng Z
J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27146447
[TBL] [Abstract][Full Text] [Related]
22. Protective Roles of Interferon-γ in Cardiac Hypertrophy Induced by Sustained Pressure Overload.
Kimura A; Ishida Y; Furuta M; Nosaka M; Kuninaka Y; Taruya A; Mukaida N; Kondo T
J Am Heart Assoc; 2018 Mar; 7(6):. PubMed ID: 29555642
[TBL] [Abstract][Full Text] [Related]
23. Role of NEK6 in tumor promoter-induced transformation in JB6 C141 mouse skin epidermal cells.
Jeon YJ; Lee KY; Cho YY; Pugliese A; Kim HG; Jeong CH; Bode AM; Dong Z
J Biol Chem; 2010 Sep; 285(36):28126-33. PubMed ID: 20595392
[TBL] [Abstract][Full Text] [Related]
24. H11 kinase is a novel mediator of myocardial hypertrophy in vivo.
Depre C; Hase M; Gaussin V; Zajac A; Wang L; Hittinger L; Ghaleh B; Yu X; Kudej RK; Wagner T; Sadoshima J; Vatner SF
Circ Res; 2002 Nov; 91(11):1007-14. PubMed ID: 12456486
[TBL] [Abstract][Full Text] [Related]
25. H-Ras Isoform Mediates Protection Against Pressure Overload-Induced Cardiac Dysfunction in Part Through Activation of AKT.
Matsuda T; Jeong JI; Ikeda S; Yamamoto T; Gao S; Babu GJ; Zhai P; Del Re DP
Circ Heart Fail; 2017 Feb; 10(2):. PubMed ID: 28193718
[TBL] [Abstract][Full Text] [Related]
26. miR-29a promotes pathological cardiac hypertrophy by targeting the PTEN/AKT/mTOR signalling pathway and suppressing autophagy.
Shi JY; Chen C; Xu X; Lu Q
Acta Physiol (Oxf); 2019 Oct; 227(2):e13323. PubMed ID: 31162869
[TBL] [Abstract][Full Text] [Related]
27. Allicin attenuates pathological cardiac hypertrophy by inhibiting autophagy via activation of PI3K/Akt/mTOR and MAPK/ERK/mTOR signaling pathways.
Ba L; Gao J; Chen Y; Qi H; Dong C; Pan H; Zhang Q; Shi P; Song C; Guan X; Cao Y; Sun H
Phytomedicine; 2019 May; 58():152765. PubMed ID: 31005720
[TBL] [Abstract][Full Text] [Related]
28. Yes-associated protein (YAP) mediates adaptive cardiac hypertrophy in response to pressure overload.
Byun J; Del Re DP; Zhai P; Ikeda S; Shirakabe A; Mizushima W; Miyamoto S; Brown JH; Sadoshima J
J Biol Chem; 2019 Mar; 294(10):3603-3617. PubMed ID: 30635403
[TBL] [Abstract][Full Text] [Related]
29. Disruption of tumor necrosis factor receptor associated factor 5 exacerbates pressure overload cardiac hypertrophy and fibrosis.
Bian Z; Dai J; Hiroyasu N; Guan H; Yuan Y; Gan L; Zhou H; Zong J; Zhang Y; Li F; Yan L; Shen D; Li H; Tang Q
J Cell Biochem; 2014 Feb; 115(2):349-58. PubMed ID: 24038435
[TBL] [Abstract][Full Text] [Related]
30. Activation of distinct signal transduction pathways in hypertrophied hearts by pressure and volume overload.
Miyamoto T; Takeishi Y; Takahashi H; Shishido T; Arimoto T; Tomoike H; Kubota I
Basic Res Cardiol; 2004 Sep; 99(5):328-37. PubMed ID: 15309410
[TBL] [Abstract][Full Text] [Related]
31. Nek6 is involved in G2/M phase cell cycle arrest through DNA damage-induced phosphorylation.
Lee MY; Kim HJ; Kim MA; Jee HJ; Kim AJ; Bae YS; Park JI; Chung JH; Yun J
Cell Cycle; 2008 Sep; 7(17):2705-9. PubMed ID: 18728393
[TBL] [Abstract][Full Text] [Related]
32. Vinexin-β protects against cardiac hypertrophy by blocking the Akt-dependent signalling pathway.
Chen K; Gao L; Liu Y; Zhang Y; Jiang DS; Wei X; Zhu XH; Zhang R; Chen Y; Yang Q; Kioka N; Zhang XD; Li H
Basic Res Cardiol; 2013 Mar; 108(2):338. PubMed ID: 23429936
[TBL] [Abstract][Full Text] [Related]
33. NIMA-related kinase-6 (NEK6) as an executable target in cancer.
Panchal NK; Mohanty S; Prince SE
Clin Transl Oncol; 2023 Jan; 25(1):66-77. PubMed ID: 36074296
[TBL] [Abstract][Full Text] [Related]
34. FKBP12.6 protects heart from AngII-induced hypertrophy through inhibiting Ca
Xiao YF; Zeng ZX; Guan XH; Wang LF; Wang CJ; Shi H; Shou W; Deng KY; Xin HB
J Cell Mol Med; 2018 Jul; 22(7):3638-3651. PubMed ID: 29682889
[TBL] [Abstract][Full Text] [Related]
35. Novel Role for Pleckstrin Homology-Like Domain Family A, Member 3 in the Regulation of Pathological Cardiac Hypertrophy.
Liu J; Liu X; Hui X; Cai L; Li X; Yang Y; Shu S; Wang F; Xia H; Li S
J Am Heart Assoc; 2019 Aug; 8(16):e011830. PubMed ID: 31426686
[TBL] [Abstract][Full Text] [Related]
36. C1q-TNF-related protein-3 attenuates pressure overload-induced cardiac hypertrophy by suppressing the p38/CREB pathway and p38-induced ER stress.
Zhang B; Zhang P; Tan Y; Feng P; Zhang Z; Liang H; Duan W; Jin Z; Wang X; Liu J; Gao E; Yu S; Yi D; Sun Y; Yi W
Cell Death Dis; 2019 Jul; 10(7):520. PubMed ID: 31285424
[TBL] [Abstract][Full Text] [Related]
37. Toll-interacting protein (Tollip) negatively regulates pressure overload-induced ventricular hypertrophy in mice.
Liu Y; Jiang XL; Liu Y; Jiang DS; Zhang Y; Zhang R; Chen Y; Yang Q; Zhang XD; Fan GC; Li H
Cardiovasc Res; 2014 Jan; 101(1):87-96. PubMed ID: 24285748
[TBL] [Abstract][Full Text] [Related]
38. Glycogen synthase kinase-3alpha reduces cardiac growth and pressure overload-induced cardiac hypertrophy by inhibition of extracellular signal-regulated kinases.
Zhai P; Gao S; Holle E; Yu X; Yatani A; Wagner T; Sadoshima J
J Biol Chem; 2007 Nov; 282(45):33181-91. PubMed ID: 17855351
[TBL] [Abstract][Full Text] [Related]
39. Hyperoside Protects Against Pressure Overload-Induced Cardiac Remodeling via the AKT Signaling Pathway.
Wang X; Liu Y; Xiao L; Li L; Zhao X; Yang L; Chen N; Gao L; Zhang J
Cell Physiol Biochem; 2018; 51(2):827-841. PubMed ID: 30466089
[TBL] [Abstract][Full Text] [Related]
40. Lysosomal cysteine peptidase cathepsin L protects against cardiac hypertrophy through blocking AKT/GSK3beta signaling.
Tang Q; Cai J; Shen D; Bian Z; Yan L; Wang YX; Lan J; Zhuang GQ; Ma WZ; Wang W
J Mol Med (Berl); 2009 Mar; 87(3):249-60. PubMed ID: 19096818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
